The Plant Alkaloid Harmaline Blocks the Voltage-Gated Sodium Channel Nav1.7: A Study Using an Automated Patch-Clamp
International Journal of Molecular Sciences · 13.05.2025 · 26 (10) · 4636
DOI: 10.3390/ijms26104636 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.05.2025. Verfasst von Jörg Eisfeld und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathophysiology, University Medicine Greifswald, Martin-Luther-Str. 6, D-17489 Greifswald, Germany. Hauptthemen laut MEDLINE: NAV1.7 Voltage-Gated Sodium Channel, Harmaline, Voltage-Gated Sodium Channel Blockers, Sodium Channel Blockers. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Bundesministerium für Wirtschaft und Energie (BMWi), European Social Fund (ESF).
Abstract (Originalsprache)
The voltage-gated sodium channel Nav1.7 is essential for pain perception and is an interesting target for the development of pain-relieving substances. Here, we investigated whether the Nav1.7 channel is sensitive to harmaline, an alkaloid produced by the North African plant Peganum harmala. To this end, we used Chinese hamster ovary (CHO) cells expressing the human Nav1.7 channel and studied Na+ channel pharmacology with an automated patch-clamp technique. Cells stimulated with depolarizing voltage pulses responded with typical transient inward currents. The Na+ channel blocker ranolazine inhibited whole-cell currents in a concentration-dependent manner (IC50: 12.1 µM). Harmaline inhibited both peak and late Na+ currents. A complete block was achieved at 300 µM of harmaline, with half maximum inhibition occurring at 35.5 µM. In contrast to ranolazine, the effect of harmaline was voltage independent. Neither the current/voltage curves nor the steady-state inactivation curves were shifted in response to drug application (30 µM). We conclude that the plant alkaloid harmaline, which is used in traditional medicine in North Africa, is an effective blocker of the voltage-gated Na+ channel Nav1.7. Our results offer a rationale for the use of harmaline against certain pain syndromes and rise hopes for the development of a new class of anti-nociceptive drugs targeting Nav1.7.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pathophysiology, University Medicine Greifswald, Martin-Luther-Str. 6, D-17489 Greifswald, Germany.
- Cytocentrics Bioscience GmbH, 18059 Rostock, Germany.
- Laboratoire de Neurosciences, Université Hassan II Casablanca, Mohammedia 28806, Morocco.
- Institute of Physiology, University Medicine Greifswald, Friedrich-Ludwig-Jahn Str. 15a, D-17475 Greifswald, Germany.
ORCID-Profile: Heinrich Brinkmeier
Förderung
- German Bundesministerium für Wirtschaft und Energie (BMWi)
- European Social Fund (ESF)
Zitieren
APA
Eisfeld, J., Schumacher, M., Krautwald, M., Wierschke, S., Qin, L., Fechtali, T., & Brinkmeier, H. (2025). The Plant Alkaloid Harmaline Blocks the Voltage-Gated Sodium Channel Nav1.7: A Study Using an Automated Patch-Clamp. International Journal of Molecular Sciences, 26(10), 4636. https://doi.org/10.3390/ijms26104636
Vancouver
Eisfeld J, Schumacher M, Krautwald M, Wierschke S, Qin L, Fechtali T, et al. The Plant Alkaloid Harmaline Blocks the Voltage-Gated Sodium Channel Nav1.7: A Study Using an Automated Patch-Clamp. International Journal of Molecular Sciences. 2025;26(10):4636. doi:10.3390/ijms26104636
BibTeX
@article{Eisfeld2025,
author = {Eisfeld, Jörg and Schumacher, Marina and Krautwald, Mirjam and Wierschke, Stephan and Qin, Lu and Fechtali, Taoufiq and Brinkmeier, Heinrich},
title = {The Plant Alkaloid Harmaline Blocks the Voltage-Gated Sodium Channel Nav1.7: A Study Using an Automated Patch-Clamp},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {10},
pages = {4636},
doi = {10.3390/ijms26104636}
}
EUVIMED